Laboratory Corporate Bonds and Leverage Analysis
| LH Stock | USD 242.15 3.42 1.43% |
Laboratory holds a debt-to-equity ratio of 0.628. As of now, Laboratory's Debt To Equity is decreasing as compared to previous years. The Laboratory's current Interest Debt Per Share is estimated to increase to 65.41, while Short and Long Term Debt Total is projected to decrease to under 3 B. With a high degree of financial leverage come high-interest payments, which usually reduce Laboratory's Earnings Per Share (EPS).
Asset vs Debt
Equity vs Debt
Laboratory's liquidity is one of the most fundamental aspects of both its future profitability and its ability to meet different types of ongoing financial obligations. Laboratory's cash, liquid assets, total liabilities, and shareholder equity can be utilized to evaluate how much leverage the Company is using to sustain its current operations. For traders, higher-leverage indicators usually imply a higher risk to shareholders. In addition, it helps Laboratory Stock's retail investors understand whether an upcoming fall or rise in the market will negatively affect Laboratory's stakeholders.
For most companies, including Laboratory, marketable securities, inventories, and receivables are the most common assets that could be converted to cash. However, for Laboratory of, the most critical issue when managing liquidity is ensuring that current assets are properly aligned with current liabilities. If they are not, Laboratory's management will need to obtain alternative financing to ensure there are always enough cash equivalents on the balance sheet to meet obligations.
Price Book 2.4789 | Book Value 97.613 | Operating Margin 0.0829 | Profit Margin 0.0343 | Return On Assets 0.0396 |
Laboratory |
Given the importance of Laboratory's capital structure, the first step in the capital decision process is for the management of Laboratory to decide how much external capital it will need to raise to operate in a sustainable way. Once the amount of financing is determined, management needs to examine the financial markets to determine the terms in which the company can boost capital. This move is crucial to the process because the market environment may reduce the ability of Laboratory of to issue bonds at a reasonable cost.
Laboratory Debt to Cash Allocation
As Laboratory of follows its natural business cycle, the capital allocation decisions will not magically go away. Laboratory's decision-makers have to determine if most of the cash flows will be poured back into or reinvested in the business, reserved for other projects beyond operational needs, or paid back to stakeholders and investors.
Laboratory of reports 5.95 B of total liabilities with total debt to equity ratio (D/E) of 0.63, which is normal for its line of buisiness. Laboratory has a current ratio of 1.7, which is generally considered normal. Note however, debt could still be an excellent tool for Laboratory to invest in growth at high rates of return. Laboratory Common Stock Shares Outstanding Over Time
Laboratory Assets Financed by Debt
The debt-to-assets ratio shows the degree to which Laboratory uses debt to finance its assets. It includes both long-term and short-term borrowings maturing within one year. It also includes both tangible and intangible assets, such as goodwill.Laboratory Debt Ratio | 40.0 |
Laboratory Corporate Bonds Issued
Most Laboratory bonds can be classified according to their maturity, which is the date when Laboratory of has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
Laboratory Net Debt
Net Debt |
|
Understaning Laboratory Use of Financial Leverage
Understanding the composition and structure of Laboratory's debt gives an idea of how risky is the capital structure of the business and if it is worth investing in it. The degree of Laboratory's financial leverage can be measured in several ways, including by ratios such as the debt-to-equity ratio (total debt / total equity), equity multiplier (total assets / total equity), or the debt ratio (total debt / total assets).
| Last Reported | Projected for Next Year | ||
| Net Debt | 5.4 B | 5.7 B | |
| Short and Long Term Debt Total | 6 B | 3 B | |
| Short Term Debt | 1.3 B | 1.4 B | |
| Long Term Debt | 4.1 B | 3.1 B | |
| Long Term Debt Total | 5.9 B | 4.8 B | |
| Short and Long Term Debt | 999.8 M | 1 B | |
| Net Debt To EBITDA | 4.03 | 3.39 | |
| Debt To Equity | 0.66 | 1.18 | |
| Interest Debt Per Share | 62.30 | 65.41 | |
| Debt To Assets | 0.31 | 0.40 | |
| Long Term Debt To Capitalization | 0.34 | 0.46 | |
| Total Debt To Capitalization | 0.40 | 0.51 | |
| Debt Equity Ratio | 0.66 | 1.18 | |
| Debt Ratio | 0.31 | 0.40 | |
| Cash Flow To Debt Ratio | 0.25 | 0.24 |
Currently Active Assets on Macroaxis
Check out the analysis of Laboratory Fundamentals Over Time. You can also try the Bollinger Bands module to use Bollinger Bands indicator to analyze target price for a given investing horizon.
Is Health Care Providers & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Laboratory. If investors know Laboratory will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Laboratory listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.05) | Dividend Share 2.88 | Earnings Share 5.28 | Revenue Per Share 151.028 | Quarterly Revenue Growth 0.074 |
The market value of Laboratory is measured differently than its book value, which is the value of Laboratory that is recorded on the company's balance sheet. Investors also form their own opinion of Laboratory's value that differs from its market value or its book value, called intrinsic value, which is Laboratory's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Laboratory's market value can be influenced by many factors that don't directly affect Laboratory's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Laboratory's value and its price as these two are different measures arrived at by different means. Investors typically determine if Laboratory is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Laboratory's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
What is Financial Leverage?
Financial leverage is the use of borrowed money (debt) to finance the purchase of assets with the expectation that the income or capital gain from the new asset will exceed the cost of borrowing. In most cases, the debt provider will limit how much risk it is ready to take and indicate a limit on the extent of the leverage it will allow. In the case of asset-backed lending, the financial provider uses the assets as collateral until the borrower repays the loan. In the case of a cash flow loan, the general creditworthiness of the company is used to back the loan. The concept of leverage is common in the business world. It is mostly used to boost the returns on equity capital of a company, especially when the business is unable to increase its operating efficiency and returns on total investment. Because earnings on borrowing are higher than the interest payable on debt, the company's total earnings will increase, ultimately boosting stockholders' profits.Leverage and Capital Costs
The debt to equity ratio plays a role in the working average cost of capital (WACC). The overall interest on debt represents the break-even point that must be obtained to profitability in a given venture. Thus, WACC is essentially the average interest an organization owes on the capital it has borrowed for leverage. Let's say equity represents 60% of borrowed capital, and debt is 40%. This results in a financial leverage calculation of 40/60, or 0.6667. The organization owes 10% on all equity and 5% on all debt. That means that the weighted average cost of capital is (.4)(5) + (.6)(10) - or 8%. For every $10,000 borrowed, this organization will owe $800 in interest. Profit must be higher than 8% on the project to offset the cost of interest and justify this leverage.Benefits of Financial Leverage
Leverage provides the following benefits for companies:- Leverage is an essential tool a company's management can use to make the best financing and investment decisions.
- It provides a variety of financing sources by which the firm can achieve its target earnings.
- Leverage is also an essential technique in investing as it helps companies set a threshold for the expansion of business operations. For example, it can be used to recommend restrictions on business expansion once the projected return on additional investment is lower than the cost of debt.